The novel GPRC5D-targeted CAR T-cell therapy, known as arlocabtagene autoleucel (arlo-cel), has demonstrated significant...
Harvard Medical School
URGENT UPDATE: A rising trend in male body dysmorphic disorder (BDD) is demanding immediate...